Healthcare provider profile · identity verified

Kent D Schnell, MD

Allopathic & Osteopathic Physicians|Internal Medicine · PASADENA, TX · NPI 1083797799

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Kent D Schnell, MD received $15.11 in general payments during 2025 across 1 reported records.

Lilly USA, LLC accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 43 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 118 claims for Mounjaro by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$15.11

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$15.11	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$15.11	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
MOUNJARO Normalized: mounjaro	Drug	Lilly USA, LLC	$15.11	1	2025
Source payment records 2025-07-25 · Lilly USA, LLC · $15.11 · Open Payments source
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$15.11	1	2025
Source payment records 2025-07-25 · Lilly USA, LLC · $15.11 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
MOUNJARO mounjaro	2025	Mounjaro	2024	118	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	43	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	118	19

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	646	191
Levothyroxine Sodium	Levothyroxine Sodium	548	158
Zolpidem Tartrate	Zolpidem Tartrate	492	88
Lisinopril	Lisinopril	356	102
Alprazolam	Alprazolam	342	57
Amlodipine Besylate	Amlodipine Besylate	336	101
Pantoprazole Sodium	Pantoprazole Sodium	302	98
Metformin Hcl	Metformin Hcl	299	87
Gabapentin	Gabapentin	294	82
Prednisone	Prednisone	278	172
Cephalexin	Cephalexin	270	189
Citalopram Hbr	Citalopram Hydrobromide	269	63
Glimepiride	Glimepiride	256	79
Losartan Potassium	Losartan Potassium	250	76
Meloxicam	Meloxicam	220	66
Ozempic	Semaglutide	217	43
Montelukast Sodium	Montelukast Sodium	208	72
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	203	26
Omeprazole	Omeprazole	200	59
Tramadol Hcl	Tramadol Hcl	184	49
Metoprolol Tartrate	Metoprolol Tartrate	178	56
Tamsulosin Hcl	Tamsulosin Hcl	175	60
Rosuvastatin Calcium	Rosuvastatin Calcium	168	50
Furosemide	Furosemide	167	61
Lorazepam	Lorazepam	152	27
Duloxetine Hcl	Duloxetine Hcl	146	32
Diazepam	Diazepam	144	31
Hydrochlorothiazide	Hydrochlorothiazide	144	45
Metoprolol Succinate	Metoprolol Succinate	142	42
Clopidogrel	Clopidogrel Bisulfate	140	46
Testosterone Cypionate	Testosterone Cypionate	139	45
Pregabalin	Pregabalin	135	27
Atenolol	Atenolol	133	39
Azithromycin	Azithromycin	131	109
Alendronate Sodium	Alendronate Sodium	127	39
Temazepam	Temazepam	125	22
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	120	17
Levofloxacin	Levofloxacin	120	88
Mounjaro	Tirzepatide	118	19
Simvastatin	Simvastatin	116	30
Ondansetron Hcl	Ondansetron Hcl	115	46
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	111	78
Dicyclomine Hcl	Dicyclomine Hcl	107	46
Eliquis	Apixaban	107	22
Allopurinol	Allopurinol	105	31
Pioglitazone Hcl	Pioglitazone Hcl	98	31
Sertraline Hcl	Sertraline Hcl	96	25
Buspirone Hcl	Buspirone Hcl	94	26
Donepezil Hcl	Donepezil Hcl	94	34
Lovastatin	Lovastatin	94	23
Trazodone Hcl	Trazodone Hcl	94	24
Synthroid	Levothyroxine Sodium	88	22
Clonazepam	Clonazepam	87	14
Acetaminophen-Codeine	Acetaminophen With Codeine	80	17
Carvedilol	Carvedilol	80	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	77	62
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	25
Potassium Chloride	Potassium Chloride	76	25
Bupropion Xl	Bupropion Hcl	75	19
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	74	17
Escitalopram Oxalate	Escitalopram Oxalate	72	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	21
Januvia	Sitagliptin Phosphate	65	15
Tizanidine Hcl	Tizanidine Hcl	65	20
Famotidine	Famotidine	63	20
Quetiapine Fumarate	Quetiapine Fumarate	61	suppressed
Clonidine Hcl	Clonidine Hcl	59	29
Fluoxetine Hcl	Fluoxetine Hcl	59	17
Liothyronine Sodium	Liothyronine Sodium	59	16
Dexamethasone	Dexamethasone	58	57
Ibuprofen	Ibuprofen	58	19
Nortriptyline Hcl	Nortriptyline Hcl	58	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	56	11
Memantine Hcl	Memantine Hcl	56	16
Diclofenac Sodium	Diclofenac Sodium	54	17
Fluconazole	Fluconazole	54	41
Pravastatin Sodium	Pravastatin Sodium	54	17
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	53	33
Terbinafine Hcl	Terbinafine Hcl	52	20
Bumetanide	Bumetanide	50	16
Zolpidem Tartrate Er	Zolpidem Tartrate	48	suppressed
Estradiol	Estradiol	47	15
Glipizide	Glipizide	46	14
Ezetimibe	Ezetimibe	43	16
Jardiance	Empagliflozin	43	suppressed
Raloxifene Hcl	Raloxifene Hcl	43	11
Olmesartan Medoxomil	Olmesartan Medoxomil	42	15
Aripiprazole	Aripiprazole	41	14
Valacyclovir	Valacyclovir Hcl	41	25
Albuterol Sulfate Hfa	Albuterol Sulfate	40	21
Metformin Hcl Er	Metformin Hcl	40	suppressed
Xarelto	Rivaroxaban	40	11
Methocarbamol	Methocarbamol	39	19
Finasteride	Finasteride	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	38	14
Benazepril Hcl	Benazepril Hcl	36	suppressed
Meclizine Hcl	Meclizine Hcl	36	15
Doxycycline Hyclate	Doxycycline Hyclate	34	33
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Nifedipine Er	Nifedipine	34	12
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	11
Myrbetriq	Mirabegron	33	suppressed
Topiramate	Topiramate	32	suppressed
Ramipril	Ramipril	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Celecoxib	Celecoxib	30	suppressed
Sucralfate	Sucralfate	30	13
Nebivolol Hcl	Nebivolol Hcl	29	11
Ondansetron Odt	Ondansetron	29	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Baclofen	Baclofen	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Metronidazole	Metronidazole	27	22
Mupirocin	Mupirocin	27	18
Dexlansoprazole Dr	Dexlansoprazole	26	suppressed
Edarbi	Azilsartan Medoxomil	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Digoxin	Digoxin	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Linzess	Linaclotide	23	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Cefuroxime	Cefuroxime Axetil	21	19
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	20	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Naproxen	Naproxen	20	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Fluticasone Propionate	Fluticasone Propionate	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	17
Nitroglycerin	Nitroglycerin	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	14
Gemfibrozil	Gemfibrozil	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Armour Thyroid	Thyroid,pork	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	16	14
Jantoven	Warfarin Sodium	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Dutasteride	Dutasteride	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Butorphanol Tartrate	Butorphanol Tartrate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Concerta	Methylphenidate Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Ritalin	Methylphenidate Hcl	12	suppressed
Colchicine	Colchicine	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$15.11 · 1 records	Lilly USA, LLC	MOUNJARO, ZEPBOUND	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Mounjaro play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error